A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Related Posts

GUIDE and Beyond: Strategies for Comprehensive Dementia Care Integration

Haggerty KL, Reuben DB, Stoeckle R, Bass D, Boustani M, Clevenger C, Kremer I, Lee DR, Johnson M, Minyo MJ, Possin KL, Samus QM, Spragens[...]

From Ancient Enemas to Tube Feeding, II: Clinical Outcomes and Future Directions Surrounding Commercial Versus Food-Based Formulas in Critical Illness

Gandhi SN, Song Y, Landry MJ, Malhotra A, Loomba R, Martin JL, Kamdar BB. From Ancient Enemas to Tube Feeding, II: Clinical Outcomes and Future[...]

Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial

Fung CH, Mak S, Ash G, Der-McLeod E, Ereso J, Naeem S, Liu J, Ghadimi S, Te TT, Chan V, Hurtado J, Wong S, Zeidler[...]